丹蒌片治疗痰瘀互结型非血运重建急性冠脉综合征的临床观察

鲜玉琼; 李岩松; 夏静雯; 江冰; 蒋年新; 魏永; 杨慰

丹蒌片治疗痰瘀互结型非血运重建急性冠脉综合征的临床观察

上海市第七人民医院心血管病科，上海 200137

计量
- 文章访问数: 1116
- HTML全文浏览量: 2
- PDF下载量: 1132
- 被引次数: 0
出版历程
- 收稿日期: 2014-12-07
- 修回日期: 2015-01-09
- 刊出日期: 2015-03-10

The Clinical Efficacy of Danlou Tablet in Non-revascularization Patients With Acute Coronary Syndrome and Phlegm and Blood Stasis Syndrome Type

摘要

摘要: 目的观察丹蒌片治疗痰瘀互结型非血运重建急性冠脉综合征（ACS）的临床疗效。方法选择因各种原因未能行血运重建治疗的中医辨证为痰瘀互结证的ACS患者70例，随机分配至对照组和治疗组，对照组给予单纯的标准化西医治疗，治疗组在标准化西医治疗基础上加用中成药丹蒌片（每次1.5 g，1日3次），疗程1个月。观察治疗前后2组患者心绞痛发作情况（程度、频率、持续时间）、硝酸甘油使用情况（用量、使用后心绞痛缓解时间）及心绞痛积分，并对治疗前后中医临床证候（包括：胸闷、胸痛及其发作频率和持续时间、心悸、气短、乏力及证候总评分）进行评分；观察治疗前后2组患者血脂[总胆固醇（TC）、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)]及超敏C反应蛋白（hs-CRP）的变化。比较2组患者心绞痛疗效、中医临床证候评分及血生化改变情况。结果治疗组心绞痛总有效率（85.29%）显著优于对照组（48.48%），P<0.01。与本组治疗前相比，2组患者治疗后的心绞痛发作频率、持续时间、服用硝酸甘油后心绞痛缓解时间、硝酸甘油使用量、心绞痛积分、中医临床证候评分及证候总评分均显著降低（P<0.01）。2组治疗后相比，治疗组显著低于对照组（P<0.05~0.01）。治疗组中医临床证候改善情况（证候评分总有效率79.41%）显著优于对照组(证候评分总有效率45.45%），P<0.01。2组治疗后TC、LDL-C（P<0.01）及hs-CRP（P<0.05）水平均显著低于同组治疗前，2组治疗后比较，治疗组hs-CRP显著低于对照组（P<0.05）。结论丹蒌片对痰瘀互结型非血运重建急性冠脉综合征患者的心绞痛及中医临床证候有显著改善作用，并可能抑制炎症反应，稳定斑块。
- 急性冠脉综合征 /
- 痰瘀互结证 /
- 丹蒌片 /
- 临床疗效
Abstract: OBJECTIVE To investigate the clinical efficacy of Danlou tablet in Non-revascularization Patients with acute coronary syndrome (ACS)and phlegm and blood stasis syndrome type(PBSST). METHODS 70 ACS patients with PBSST for various reasons failed revascularization therapy were randomly assigned to the control group and the treatment group. The control group was given a standardized western medicine treatment and the treatment group was given Danlou tablets (every time 1.5g， 3 times a day) based on standardized western medicine treatment for a month. Angina episodes (intensity， frequency， duration)， nitroglycerin use (consumption， angina relief time after taking nitroglycerin ) and the score of angina， traditional Chinese Medicine（TCM）clinical syndrome (including: chest pain or tightness and its frequency and duration， palpitations， shortness of breath， fatigue and total syndrome score)， lipids including total cholesterol (TC)， low-density lipoprotein cholesterol (LDL-C)， high density lipoprotein cholesterol (HDL-C)， triglycerides (TG)] and hypersensitive C-reactive protein (hs-CRP) were observed in the two groups of patients before and after treatment. The clinical efficacy of angina，the score of TCM clinical syndrome and blood biochemical changes were recorded and compared between the two groups. RESULT The total effective rate of angina (85.29%) was significantly better than that of the control group (48.48%)(P<0.01). Compared with the same group before treatment， the frequency and duration of angina， the angina relief time after taking nitroglycerin， the amount of nitroglycerin， the score of angina and TCM clinical syndromes and the total score of syndrome，all these were significantly lower (P<0.01) in the two groups of patients after treatment. Compared with the control group， the frequency and duration of angina， the angina relief time after taking nitroglycerin， the amount of nitroglycerin， the total score of TCM clinical syndrome (P<0.05) and the score of angina (P<0.01) were significantly lower in the treatment group after treatment. The improvement of TCM clinical syndromes in the treatment group (the total efficiency of syndrome score was 79.41%) was significantly better than the control group (the total efficiency of syndrome score was 45.45%) (P<0.01). TC， LDL-C(P<0.01) and hs-CRP (P<0.05) levels after treatment were significantly lower than before. After treatment， hs-CRP in the treatment group was significantly lower compared with the control group(P<0.05). CONCLUSION Danlou tablet can promote a significant improvement to angina and TCM clinical syndromes in Non-revascularization Patients with ACS and PBSST， inhibit the inflammation， and show plaque stabilizing effects.
- Acute coronary syndrome /
- phlegm and blood stasis syndrome type /
- Danlou tablet /
- clinical efficacy

HTML全文

参考文献(20)

[1]	〖JP3〗苑飞，宋现涛，吕树铮．中国内地2008年经皮冠状动脉介入治疗调查注册研究分析[J]．中华心血管病杂志，2010，38（7）：629-632．〖JP〗
[2]	Yuan F， Song XT， Lv SZ. Percutaneous coronary intervention in mainland China in 2008: register results[J]. Chin J Cardiol， 2010， 38(7): 629-632.
[3]	急性冠状动脉综合征非血运重建患者的抗血小板治疗的中国专家共识组.急性冠状动脉综合征非血运重建患者的抗血小板治疗中国专家共识（修订案）[J].中国医刊，2011，46（5）:79-85.
[4]	Acute coronary syndromes of antiplatelet therapy in patients with non reascularization China expert consensus groups. Acute coronary syndrome antiplatelet therapy in patients without reascularization China expert consensus (amendment)[J]. Chin J Med， 2011， 46(5):79-85.
[5]	卓思源．中医药治疗冠心病心绞痛近况[J]．中国中医急症，2007，16（5）：594-595．
[6]	Zhuo SY. TCM in treating coronary heart disease and angina pectoris[J]. J Emerg Tradit Chin Med， 2007， 16(5)：594-595．
[7]	曹洪欣，张华敏．痰瘀互结与冠心病发病机理辨识[J]．中医药学刊，2001，19（6）：544-545．
[8]	Cao HX， Zhang HM. Recognization on the attack mechanism of coronary heart disease and interelation between phlegm and stasis[J]. J Tradit Chin Med Pharm， 2001， 19(6): 544-545.
[9]	中华医学会心血管分会、中华心血管病杂志编辑委员会.不稳定型心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志.2007，35(4):295-304.
[10]	The Chinese medical association cardiovascular branch， Editorial Board of Chinese Journal of Cardiology.Unstable angina and non-ST segment elevation myocardial infarction diagnosis and treatment guidelines[J]. Chin J Cardiol， 2007，35(4):295-304.
[11]	中华医学会心血管病分会、中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志，2010，38(8):675-690.
[12]	The Chinese medical association cardiovascular branch， Editorial Board of Chinese Journal of Cardiology. Diagnosis and treatment of acute ST segment elevation myocardial infarction[J]. Chin J Cardiol， 2010， 38(8):675-690.
[13]	中药新药临床研究指导原则[S].北京：中国医药科技出版社，2002:68-73.
[14]	Clinical guideline of new drugs for traditional Chinese medicine[S].Beijing: China medical science press， 2002， 68-73.
[15]	朱文锋，何清湖．现代中医临床诊断学[M]．北京：人民卫生出版社，2003：396-399．
[16]	Zhu WF， He QH. Modern clinical diagnostics of traditional Chinese medicine[M]. Beijing: People's medical publishing house， 2003:396-399.
[17]	〖JP3〗1979年全国中西医结合治疗冠心病心绞痛及心律失常座谈会.冠心病心绞痛及心电图疗效评定标准[J].中国药事，1987，1（2）：71-74.〖JP〗
[18]	〖JP2〗The 1979 national symposium of treatment of coronary heart disease， angina by integrated traditional and western. Therapeutic effect evaluation standard of coronary heart disease angina pectoris and electrocardiogram[J]. Chin Pharm Affair，1987，1(2)：71-74.〖JP〗
[19]	卓思源．中医药治疗冠心病心绞痛近况[J]．中国中医急症，2007，16（5）：594-595．
[20]	Zhuo SY. TCM in treating coronary heart disease and angina pectoris[J]. J Emerg Tradit Chin Med， 2007， 16(5)：594-595．